Cargando…
Butyrate, a new microbiota-dependent player in CD8+ T cells immunity and cancer therapy?
The intestinal microbiota is a new promising avenue in cancer immunotherapy, but mechanisms remain elusive. He et al. demonstrate that butyrate, a bacterial metabolite, enhances the CD8+ T cell response and improve chemotherapy efficacy through ID2-dependent IL-12 signaling.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324458/ https://www.ncbi.nlm.nih.gov/pubmed/34337557 http://dx.doi.org/10.1016/j.xcrm.2021.100328 |